Specifically, the levels of Aβ34 depends directly on increased BACE1 levels in AD brain, i.e., Aβ34 levels were approximately twofold elevated in the brains of individuals with AD compared to non-demented controls and levels coincided with roughly twofold higher BACE1 levels in vivo. This evidence concerns the gene BACE1 and Alzheimer disease.